Akèy › Histiyositoz selil Langerhans › Texas
Etid klinik pou Histiyositoz selil Langerhans nan Texas
4 etid pou Histiyositoz selil Langerhans ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Dell Children's Medical Center of Central Texas, Austin
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- El Paso Children's Hospital, El Paso
- ak 6 plis
Ap rekriteFaz 2
180 Days – 22 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT05828069Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
- Cook Children's Health Care System, Fort Worth
Ap rekriteFaz 2
Laj 1 a 30 · Tout sèks · Mizajou Apr 7, 2026 · NCT06582745Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Medical Center- UTSW, Dallas
- Texas Children's Hospital, Houston
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 18, 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Dell Children's Medical Center, Austin
- Cook Children's Health Care System, Fort Worth
- Texas Children's Hospital, Houston
- ak 2 plis
Ap rekriteFaz 3
Jiska laj 21 · Tout sèks · Mizajou Sep 11, 2025 · NCT02670707Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.